Ticker: KPTI

Company: Karyopharm Therapeutics Inc.

Person: Stuart Poulton, officer

Transaction date: July 30, 2024

Reporting date: July 31, 2024

Average share price: 1.06

Sold 2883.0 shares for 3055.98